Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,562.9
52.1 (2.08%)

 

  • STI Straits Times Index
    2,562.9
    52.1 (2.08%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,489.3
    16.1 (1.09%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    23,701.8
    740.3 (3.22%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    2,908.5
    56.1 (1.97%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    22,077.0
    199.1 (0.91%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    4,753.6
    37.4 (0.79%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 943.1M
  • Value: 913.3M
  • Rise: 209
  • Fall: 72
  • Unch: 527

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Rex Intl0.183+0.028
ComfortDelGro1.410-0.030
SPH1.300+0.020
Medtecs Intl0.280+0.025
Forise Intl0.009-0.001
Singapore-eDev0.061+0.006
Mapletree Log Tr2.060+0.010
Interra Resource^0.063+0.007
YZJ Shipbldg SGD0.975+0.035
Dyna-Mac0.122+0.006

World Indices

World Indices
Name Last Change
Nasdaq 9,489.9 +120.9
HSI 23,701.8 +740.4
HSCEI 9,834.6 +273.6
Jakarta 4,753.6 +37.4
Nikkei 225 22,087.5 +209.6
SSE Comp 2,908.5 +56.1
Shanghai A 3,048.7 +58.8
Shanghai B 205.8 +5.6
KOSPI 2,059.6 +30.0

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

NOVABAY PHARMACEUTICALS INC NOVABAY PHARMACEUTICALS
Updated on 29 May 2020 (End of trading day)
Last (USD): 0.845 Change: -0.035 High: 0.870 Remarks: -
Change (%): -3.98 Low: 0.828
Open 0.860 Yesterday's Close 0.88
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 937,555 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -0.68502 Trailing EPS (USD) e -0.51473 NAV (USD) b -0.0228
PE a - Trailing PE f - Price / NAV b -37.0614
Dividend (USD) d - Cash In Hand (USD) g 0.3729 Issued & Paid-up Shares c 28,810,600
Dividend Yield (%) d - Price / Cash In Hand g 2.266 Treasury Shares h -
Beta - 75 Daysi - R-Squared - 75 Days(%)i - Market Cap (M) 12.936
Beta - 500 Daysi - R-Squared - 500 Days (%)i - Enterprise Value (M) 10.612
Piotroski F Score 0 Exchange Code NBY Par Value ( $ ) n.a.
52 Weeks Volatility (%) 212.89 Free Float (%) 56.9
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 07 May 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 13 Jul 2015.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference NOVABAY PHARMACEUTICALS INC NYSE American 12.936 - - -37.0614 -
Industry Biotechnology NYSE American 118.158 - - 3.5238 -
Local Peer NANOVIRICIDES INC NYSE American 474.301 - - 61.4379 -
Local Peer CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL NYSE American 316.246 - - 358.3333 -
Local Peer PFENEX INC NYSE American 171.997 162.553 - 2.0679 -
Local Peer IBIO INC NYSE American 148.510 - - 37.4707 -
Local Peer LINEAGE CELL THERAPEUTICS INC NYSE American 132.097 - - 1.2404 -
Local Peer CEL-SCI CORP NYSE American 124.449 - - 10.1935 -
Local Peer 22ND CENTURY GROUP INC NYSE American 85.116 - - 1.4598 -
Local Peer MATINAS BIOPHARMA HOLDINGS INC NYSE American 82.775 - - 1.1240 -
Local Peer AIM IMMUNOTECH INC NYSE American 81.722 - - 2.3797 -
Local Peer PALATIN TECHNOLOGIES INC NYSE American 77.455 2.165 2.088 0.8935 -
Local Peer ARMATA PHARMACEUTICALS INC NYSE American 69.358 - - 2.0715 -
Local Peer SYNTHETIC BIOLOGICS INC NYSE American 50.837 - - -9.7396 -
Other Local Peers ORAGENICS INC (NYSE American), INDIA GLOBALIZATION CAPITAL INC (NYSE American), ACTINIUM PHARMACEUTICALS INC (NYSE American)
Global Peer AMGEN INC NASDAQ 135,120.336 17.230 17.605 14.2457 2.539
Global Peer GILEAD SCIENCES INC NASDAQ 97,598.820 18.121 19.669 4.4228 3.269
Global Peer CSL ASX 125,417.415 46.747 43.295 14.5018 0.960
Global Peer AMGEN-T HKEx 588,247.000 9.574 9.804 8.0015 4.569
Global Peer VERTEX PHARMACEUTICAL NASDAQ 74,661.405 63.444 49.414 11.5545 -
Global Peer REGENERON PHARMACEUTICALS INC NASDAQ 68,954.588 32.590 30.253 5.6832 -
Global Peer ILLUMINA INC NASDAQ 53,368.350 53.262 56.654 11.5142 -
Global Peer BIOGEN INC NASDAQ 50,113.096 8.510 8.524 3.9941 -
Global Peer AGILENT TECHNOLOGIES INC NYSE 27,292.639 25.483 39.960 5.7241 0.743
Global Peer SEATTLE GENETICS INC NASDAQ 27,213.365 - - 15.4129 -
Other Global Peers ALEXION PHARMACEUTICAL INC (NASDAQ), MODERNA INC (NASDAQ), INCYTE CORPORATION (NASDAQ), WUXI BIO (HKEx), SINO BIOPHARM (HKEx), BIOMARIN PHARMACEUTICAL (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), EXACT SCIENCES CORP (NASDAQ), BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), BEIGENE (HKEx), SAREPTA THERAPEUTICS INC (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), BIONTECH SE SPON ADS EACH REP 1 ORD SHS (NASDAQ), BIO-TECHNE CORP (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), 10X GENOMICS INC (NASDAQ), IMMUNOMEDICS INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), EXELIXIS INC (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), ACCELERON PHARMA (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), EMERGENT BIOSOLUTIONS INC (NYSE), MIRATI THERAPEUTICS INC (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), Lonza (SGX), GENSCRIPT BIO (HKEx), BLUEBIRD BIO INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), CHEMOCENTRYX INC (NASDAQ), MOMENTA PHARMACEUTICALS INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), 3SBIO (HKEx), FIBROGEN INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), UNIQURE N.V. (NASDAQ), NOVAVAX INC (NASDAQ), ALKERMES PLC (NASDAQ), ALECTOR INC (NASDAQ), VIELA BIO INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), INSMED INC (NASDAQ), BENITEC BIOPHARMA INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), ALPHAMAB-B (HKEx), EIDOS THERAPEUTICS INC (NASDAQ), ZENTALIS PHARMACEUTICALS INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), EPIZYME INC (NASDAQ), XENCOR INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), MESOBLAST LTD (ASX), MERSANA THERAPEUTICS INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), ARCUS BIOSCIENCES INC (NYSE), ADAPTIMMUNE THERAPEUTICS PLC ADS EACH REPR 6 SHS (SPONS) (NASDAQ), VIVA BIOTECH (HKEx), LUMINEX CORP(DEL) (NASDAQ), REGENXBIO INC (NASDAQ), BLACK DIAMOND THERAPEUTICS INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), CORTEXYME INC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), BEAM THERAPEUTICS INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), ARVINAS INC (NASDAQ), VERACYTE INC (NASDAQ), CYTOKINETICS INC (NASDAQ), HAOHAI BIOTEC (HKEx), COMPUGEN (NASDAQ), POLYNOVO LIMITED (ASX), ESPERION THERAPEUTICS INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), MYOVANT SCIENCES LTD (NYSE), AIMMUNE THERAPEUTICS INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), FRONTAGE (HKEx), ROCKET PHARMACEUTICALS INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), PASSAGE BIO INC (NASDAQ), MACROGENICS INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), NEXTCURE INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), IMMUNOGEN INC (NASDAQ), OMEROS CORP (NASDAQ), CUE BIOPHARMA INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), ASCENTAGE-B (HKEx), CARA THERAPEUTICS INC (NASDAQ), AVROBIO INC (NASDAQ), KADMON HLDGS INC (NYSE), MOLECULAR TEMPLATES INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), KINTOR PHARMA-B (HKEx), AVITA MEDICAL LTD SPON ADS EACH REP 20 ORD SHS (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), RETROPHIN INC (NASDAQ), AVITA MEDICAL LTD (ASX), NANTKWEST INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), ARDELYX INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), AGENUS INC (NASDAQ), BELLUS HEALTH INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), STEMLINE THERAPEUTICS INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), ATHERSYS INC (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), ANAPTYSBIO INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), SINOMAB BIO-B (HKEx), VBI VACCINES INC CDA (NASDAQ), UROGEN PHARMA LTD (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), NEOLEUKIN THERAPEUTICS INC (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), PROTHENA CORP PLC (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), ASCLETIS-B (HKEx), CYTOMX THERAPEUTICS INC (NASDAQ), XBIOTECH INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), MERUS B V (NASDAQ), PDL BIOPHARMA INC (NASDAQ), PRECIGEN INC (NASDAQ), PERSONALIS INC (NASDAQ), PROGENICS PHARMACEUTICALS INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), ESSEX BIO-TECH (HKEx), WAVE LIFE SCIENCES LTD (NASDAQ), KAMADA (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), AVID BIOSERVICES INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), GERON CORP (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), MANNKIND CORPORATION (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), VERMILLION INC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), VERASTEM INC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), LEE'S PHARM (HKEx), ADMA BIOLOGICS INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), SUMMIT THERAPEUTICS PLC ADS EACH REPR 5 ORD (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), DPHARMA (Bursa), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), ADURO BIOTECH INC (NASDAQ), CHIASMA INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), BBI LIFE SCI (HKEx), AFFIMED N V (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), MEDICINOVA INC (NASDAQ), TELIX PHARMACEUTIC (ASX), INFLARX N V (NASDAQ), XOMA CORP (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), NEUROBO PHARMACEUTICALS INC (NASDAQ), AXCELLA HEALTH INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), ARAVIVE INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), IVERIC BIO INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), VAXART INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), CHIMERIX INC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), IMV INC (NASDAQ), NEXT SCIENCE LTD (ASX), GALECTIN THERAPEUTICS INC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), ORGENESIS INC (NASDAQ), CELYAD ADS EACH REPR 1 ORD (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), CABALETTA BIO INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), MINERVA NEUROSCIENCES INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), CONTRAFECT CORP (NASDAQ), TREVENA INC (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), ENZO BIOCHEM INC (NYSE), AVEO PHARMACEUTICALS INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), SAVARA INC (NASDAQ), AXOVANT GENE THERAPIES LTD (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), GLYCOMIMETICS INC (NASDAQ), WINDTREE THERAPEUTICS INC (NASDAQ), UNI-BIO GROUP (HKEx), NEUREN PHARMACEUTICALS LTD (ASX), LUMOS PHARMA INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), COHBAR INC (NASDAQ), RECRO PHARMA INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), IMUGENE LIMITED (ASX), ONCOLYTICS BIOTECH INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), SESEN BIO INC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), SYNLOGIC INC (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), MONOPAR THERAPEUTICS INC (NASDAQ), RESTORBIO INC (NASDAQ), OTONOMY INC (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), INVEX THERAPEUTICS LTD NPV (ASX), ANPAC BIO MEDICAL SCIENCE CO LTD SPON ADS EACH REPR 1 ORD SHS CLASS A (NASDAQ), VACCINEX INC (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), INMUNE BIO INC (NASDAQ), EQUILLIUM INC (NASDAQ), IMMUTEP LTD (ASX), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), 9 METERS BIOPHARMA INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), MIRAGEN THERAPEUTICS INC (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), SOLIGENIX INC (NASDAQ), CYNATA THERAPEUTICS LTD (ASX), ANIXA BIOSCIENCES INC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), BIOTRON (ASX), PULMATRIX INCORPORATED (NASDAQ), ADVAXIS INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), LARIMAR THERAPEUTICS INC (NASDAQ), SONNET BIOTHERAPEUTICS HLDGS INC (NASDAQ), ZAFGEN INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), MEMPHASYS LTD (ASX), ATYR PHARMA INC (NASDAQ), CT ENTERPRISE (HKEx), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), BIOSINO BIO-TEC (HKEx), BIONANO GENOMICS INC (NASDAQ), CURIS INC (NASDAQ), HOLISTA COLLTECH LIMITED (ASX), GENETIC TECHNOLOGIES (ASX), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), KAZIA THERAPEUTICS LIMITED (ASX), TOCAGEN INC (NASDAQ), BIOCARDIA INC (NASDAQ), CORREVIO PHARMA CORP (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), CCP TECHNOLOGIES LTD (ASX), EVOGENE LTD (NASDAQ), ANTEOTECH LIMITED (ASX), ALIMERA SCIENCES INC (NASDAQ), AIKIDO PHARMA INC (NASDAQ), CYCLACEL PHARMACEUTICALS INC (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), OCUGEN INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), Suntar Eco-City^ (SGX), SIENNA CANCER DIAGNOSTICS LTD (ASX), CONATUS PHARMACEUTICALS INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), BIONOMICS LTD (ASX), UNUM THERAPEUTICS INC (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), SENECA BIOPHARMA INC (NASDAQ), REGENT PACIFIC (HKEx), ACHIEVE LIFE SCIENCE INC (NASDAQ), REGENEUS LTD (ASX), CELLECTAR BIOSCIENCES INC (NASDAQ), ACTINOGEN MEDICAL LTD (ASX), PHIO PHARMACEUTICALS CORP (NASDAQ), RHINOMED LIMITED (ASX), PRESCIENT THERAPEUTICS LIMITED (ASX), ENDRA LIFE SCIENCES INC (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED (ASX), REXAHN PHARMACEUTICALS INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), CONTANGO ASSET MANAGEMENT LIMITED (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), PRECIPIO INC (NASDAQ), PATRYS LIMITED (ASX), ADALTA LTD (ASX), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), AVECHO BIOTECHNOLOGY LTD (ASX), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), HAO WEN HLDGS (HKEx), PLUS THERAPEUTICS INC (NASDAQ), SENESTECH INC (NASDAQ), ANATARA LIFESCIENCES LTD (ASX), XENETIC BIOSCIENCES INC (NASDAQ), CRYOSITE (ASX), AUSTRALIAN PRIMARY HEMP LTD (ASX), AMPLIA THERAPEUTICS LTD (ASX), MIDATECH PHARMA PLC SPON ADS EACH REP 5 ORD SHS(R/S) (NASDAQ), LIVING CELL TECHNOLOGIES (ASX), AURIS MEDICAL HOLDING LTD (NASDAQ), LEAF RESOURCES LTD (ASX), THERAPIX BIOSCIENCES LTD SPON ADR EACH REP 40 ORD (POST SPLIT) (NASDAQ), NANOLLOSE LTD (ASX), FACTOR THERAPEUTICS LIMITED (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.014
-1.63 %
10 Days --0.008
-0.94 %
20 Days --0.185
-17.96 %
Medium Term Return 3 Months -+0.278
+49.03 %
6 Months -+0.225
+36.29 %
1 Year -+0.536
+173.46 %
Long Term Return 2 Years --1.455
-63.26 %
3 Years --1.705
-66.86 %
5 Years --21.040
-96.14 %
Annualised Return Annualised --
-47.84 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 0.240 - 4.040 Change From 1 Year Low +0.605 % Change From 1 Year Low (%) +252.08
Change From 1 Year High -3.195 % Change From 1 Year High (%) -79.08
2 Years Range 0.229 - 4.040 Change From 2 Years Low +0.616 % Change From 2 Years Low (%) +269.00
Change From 2 Years High -3.195 % Change From 2 Years High (%) -79.08
5 Years Range 0.229 - 22.750 Change From 5 Years Low +0.616 % Change From 5 Years Low (%) +269.00
Change From 5 Years High -21.905 % Change From 5 Years High (%) -96.29
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

NovaBay Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in developing products for the eye care market. Its products include Avenova, NeutroPhase, and CelleRx. The company was founded by Ramin Najafi on January 19, 2000 and is headquartered in Emeryville, CA.

Historical Price Data

Date Open High Low Close Volume VWAP
29 May 2020 0.860 0.870 0.828 0.845 937,555 -
28 May 2020 0.894 0.894 0.870 0.880 638,285 -
27 May 2020 0.910 0.910 0.859 0.890 1,316,367 -
26 May 2020 0.870 0.895 0.860 0.890 1,273,238 -
22 May 2020 0.852 0.860 0.841 0.859 603,193 -
21 May 2020 0.860 0.862 0.835 0.862 669,583 -
20 May 2020 0.850 0.870 0.840 0.860 1,042,327 -
19 May 2020 0.873 0.878 0.823 0.870 1,501,016 -
18 May 2020 0.850 0.890 0.850 0.853 2,906,948 -
15 May 2020 0.930 0.947 0.850 0.890 3,384,557 -
14 May 2020 1.050 1.065 0.930 0.947 12,256,680 -
13 May 2020 0.980 0.980 0.923 0.950 2,430,027 -
12 May 2020 0.940 1.040 0.940 0.994 1,854,890 -
11 May 2020 0.987 1.010 0.920 1.010 1,330,864 -
08 May 2020 0.960 1.020 0.910 1.020 2,012,101 -
07 May 2020 1.130 1.140 1.010 1.080 3,484,986 -
06 May 2020 1.030 1.200 1.010 1.120 6,650,928 -
05 May 2020 1.050 1.050 0.953 0.972 1,843,552 -
04 May 2020 0.960 1.050 0.950 1.030 2,586,206 -
01 May 2020 0.930 0.988 0.920 0.944 1,572,128 -
30 Apr 2020 0.910 0.930 0.890 0.920 544,657 -
29 Apr 2020 0.941 0.950 0.911 0.937 1,242,220 -
Summary
Current 2 Weeks
(15 May 2020 to 29 May 2020)
0.930 0.947 0.823 0.845 14,273,069 -
Previous 2 Weeks
(01 May 2020 to 14 May 2020)
0.930 0.988 0.823 0.947 36,022,362 -
4 Weeks from
(02 Apr 2020 to 30 Apr 2020)
0.850 0.947 0.720 0.920 107,933,172 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.